Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia.
about
Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic reviewA bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice.'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.Clinical guide to fertility preservation in hematopoietic cell transplant recipientsFertility Preservation for Prepubertal Girls: Update and Current ChallengesInitiation of puberty in mice following decellularized ovary transplant.Alginate scaffold for organ culture of cryopreserved-thawed human ovarian cortical follicles.Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?Fertility preservation in female cancer patients: An overview.Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation.Safety of ovarian tissue autotransplantation for cancer patients.Fertility preservation in girls.A new method for evaluating the risk of transferring leukemic cells with transplanted cryopreserved ovarian tissue.Applicability of adult techniques for ovarian preservation to childhood cancer patients.Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patientsNew advances in ovarian autotransplantation to restore fertility in cancer patientsThe safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature.Synthetic polymers improve vitrification outcomes of macaque ovarian tissue as assessed by histological integrity and the in vitro development of secondary folliclesEliminating malignant contamination from therapeutic human spermatogonial stem cells.Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescenceEvidence-Based Recommendations for Fertility Preservation Options for Inclusion in Treatment Protocols for Pediatric and Adolescent Patients Diagnosed With Cancer.Oncofertility in Canada: cryopreservation and alternative options for future parenthood.Preservation of fertility in females with haematological malignancy.Fertility preservation in girls and young women.Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients.Female fertility loss and preservation: threats and opportunities.Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma.Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience.Human single follicle growth in vitro from cryopreserved ovarian tissue after slow freezing or vitrification.Strategies for overcoming oncological treatment-related ovarian dysfunction - literature review.Survival and growth of isolated pre-antral follicles from human ovarian medulla tissue during long-term 3D culture.Cryopreservation of ovarian tissue in pediatric patients undergoing sterilizing chemotherapy.Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia.Cancer and fertility preservation: international recommendations from an expert meeting.Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry.
P2860
Q26771340-8477958A-0428-40BE-BF5C-D4C4AF4B3C74Q26864087-BDEE6A8A-3D42-4D41-988F-9F9D670ACB85Q29964195-FEE68B27-7855-4E58-95AB-6E5751B6BC07Q30360464-5CA1F850-42D0-405E-B50C-DE154591BCB3Q33809651-A7DCA88F-CF92-4789-824A-51C763452929Q34015324-299A2FB6-CDCB-418A-B4CC-EE020EF6E447Q35148516-DF514651-C64B-4CCB-9E3B-D93F87A72DC4Q35204397-C3491D8C-DF9B-4B5D-A168-B397D9E58B2FQ35236668-A3A0A034-D7B6-4E19-8CA3-EF1D125814E3Q35237851-B622DE4F-1467-49D2-85E5-1737965F29E0Q35621478-DF495DB9-2B55-42A5-B101-A9FCCCF854E9Q35664382-974C2960-1DE4-4D11-90C4-C1C1016315EFQ35838156-5C8943F7-F95E-4B1C-BCE4-24D1673DA146Q36010255-8ADA0E65-8A56-4F85-9274-0D5F285EDB63Q36295588-286D85C9-ECE7-406D-A540-FA23FAFF1D54Q36434645-C3CF120B-F6B1-4EA2-9E38-E6A55E1FA315Q36490265-1B708DF2-51E0-4E00-9AAE-FDD8A9925EB1Q36557304-69E5F765-0BB0-48D3-8D99-FDA1986F6735Q36609078-E183D21B-8BBB-4CDF-BBB8-F7FDEBEB9DCEQ36733464-EFE8DBFB-1A50-4D5E-A828-BC0C614B94C1Q36908549-80870D4F-6FE4-4B80-B06C-D2776BC4D2F8Q37387472-42B49084-7AC0-4C45-ABCB-9310C3BC9564Q37557863-E885FC91-0A8D-4B42-ABCA-B13110209898Q37577667-D25A7D52-ECE3-478D-A1F8-13CB987F7190Q37874648-80CEAF61-26A5-42AF-96AF-4B643C43A3B1Q37875896-B5F8F621-6836-4378-AC50-A691D71179E4Q38014535-AC7F368C-E48D-4C43-B13C-644D695B4B06Q38057986-1971BD8F-0A11-4008-9CBA-15E0741888EEQ38184581-F1325628-BC7B-4EA3-BFAC-5A54A47B0B1CQ38397291-6750BB87-A76E-4DDB-9AD2-ACD2BA9ECCC9Q38606467-BDF3C08F-DDE8-4BE3-8F87-487C02355F42Q38741441-54A20ADA-5987-4DDE-BB35-78D3FAE762BBQ38757529-8C5DDEE3-E48A-45E9-9D10-C987E8222ECFQ38911413-FDCE8140-CD36-4953-9B96-8524FDCF86F2Q39366152-A7CC3054-FD64-40DA-9088-2DB7D9FFE40FQ39823405-F39F97BC-997E-4B9A-BC39-8EFE13AACD48Q40836470-FC6A2B16-B546-447B-B444-8F2DD063F2B1Q43057969-F66B505B-DC8B-4319-9E60-CA2DCA201736Q43106184-3011A108-BDCB-4F4E-9123-821F458A9CBBQ44303548-EE3032E8-A747-418C-8DAF-6A3913E2E1CC
P2860
Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Evidence of residual disease i ...... female patients with leukemia.
@en
Evidence of residual disease i ...... female patients with leukemia.
@nl
type
label
Evidence of residual disease i ...... female patients with leukemia.
@en
Evidence of residual disease i ...... female patients with leukemia.
@nl
prefLabel
Evidence of residual disease i ...... female patients with leukemia.
@en
Evidence of residual disease i ...... female patients with leukemia.
@nl
P2093
P50
P1476
Evidence of residual disease i ...... female patients with leukemia.
@en
P2093
Elisabeth Ralfkiær
Lars Kjeldsen
Morten Tolstrup Andersen
P304
P356
10.1016/J.FERTNSTERT.2009.11.032
P407
P577
2010-01-25T00:00:00Z